Senior Director, Corporate Strategy

About the role:

The Senior Director, Corporate Strategy is responsible for leading critical components of Takeda’s corporate strategy function, helping to ensure that corporate strategy, portfolio strategy, functional strategies, and enterprise resource allocation are all well aligned in support of scientific innovation, commercial excellence, and ultimately patient impact. Reporting to the Head of Corporate Strategy, this role partners closely with senior leaders across Strategy & Portfolio Development, R&D, commercial BUs, finance, External Portfolio Innovation, and other business functions to evaluate enterprise priorities, frame strategic choices, and develop recommendations that support sustainable growth and competitive advantage in a rapidly evolving global healthcare landscape.

The role will lead major enterprise strategy initiatives, scenario planning, evaluation of strategic alternatives, industry and competitive benchmarking, and strategic assessments of acquisitions, divestitures, and other corporate development opportunities. The Senior Director will also play a central role in developing decision materials and strategic evaluations for the Takeda Executive Team and Board of Directors.

• Lead major components of the company’s long-term corporate strategy across therapeutic areas and geographies, translating enterprise ambitions into clear strategic choices, priorities, and actions.
• Lead enterprise scenario planning and strategic foresight, evaluating alternative strategic pathways under a range of potential future industry, market, policy, geopolitical, scientific, and technology scenarios.
• Frame complex enterprise decisions by defining strategic alternatives, evaluating implications and trade-offs, and developing clear, evidence-based recommendations for senior leadership.
• Lead the analysis of major corporate strategic decisions and the development of executive summaries, evaluations, and decision materials for the Takeda Executive Team and Board of Directors.
• Conduct industry and peer benchmarking to assess relative performance, portfolio strategies, investment patterns, operating models, capabilities, and sources of competitive advantage.
• Evaluate the evolution of business models within biopharma and the broader healthcare ecosystem, including the strategic implications of artificial intelligence, digital health, new sources of scientific innovation, changing geopolitical conditions, healthcare policy, and emerging innovation ecosystems.
• Lead strategic evaluations of mergers and acquisitions, divestitures and other corporate development opportunities, including assessment of strategic fit, enterprise value creation, portfolio implications, risks, and strategic alternatives.
• Lead cross-functional strategy projects addressing enterprise growth, portfolio priorities, geographic and market expansion, capability requirements, and other high-impact strategic questions.
• Support annual strategic planning processes, ensuring that business unit, therapeutic area, portfolio, and functional strategies are coherent with the company’s long-term direction.
• Monitor global biopharma trends, competitive dynamics, capital-market developments, regulatory and policy changes, and potential disruptions, translating these developments into actionable implications for Takeda.
• Develop clear, concise, and compelling presentations, strategic narratives, and executive communications that enable informed decisions by senior leadership and the Board.
• Build alignment among senior stakeholders with differing perspectives, facilitating structured discussions around strategic options, assumptions, risks, and trade-offs.
• Apply AI, advanced analytics, and emerging technology…